The field of fetal medicine has evolved significantly over the past several decades. Our ability to identify and treat the unborn patient has been shaped by advancements in imaging technology, genetic diagnosis, an improved understanding of fetal physiology, and the development and optimization of in utero surgical techniques. The future of the field will be shaped by medical innovators pushing for the continued refinement of minimally invasive surgical technique, the application of pioneering technologies such as robotic surgery and in utero stem cell and gene therapies, and the development of innovative ex utero fetal support systems.
fetal surgery advancements, in utero intervention techniques, minimally invasive fetal therapy, robotic surgery fetal anomalies, prenatal gene therapy, stem cell therapy fetus, ex utero support systems, fetal medicine future technologies, prenatal surgical techniques
Cite this article
Bergh, E., Cara Buskmiller, & Johnson, A. (2021). The Future of Fetal Surgery. *Obstetrics and gynecology clinics of North America*, *48*(4), 745-758. https://doi.org/10.1016/j.ogc.2021.06.004
Bergh E, Cara Buskmiller, Johnson A. The Future of Fetal Surgery. Obstet Gynecol Clin North Am. 2021;48(4):745-758. doi:10.1016/j.ogc.2021.06.004
Bergh, E., et al. "The Future of Fetal Surgery." *Obstetrics and gynecology clinics of North America*, vol. 48, no. 4, 2021, pp. 745-758.
Pineles BL et al., 2023
Open Access
AJOG Global Reports
Background: Cesarean delivery is a major source of maternal morbidity, and repeat cesarean delivery accounts for 40% of cesarean delivery, but recent data on the trial of labor after cesarean and vagi...
Dawood AS et al., 2018
Open Access
Clinical and Experimental Reproductive Medicine
The purpose of this paper is to review the current clinical uses of platelet-rich plasma (PRP) in the field of gynecology. All relevant articles published from January 2000 to December 2017 were revie...
Santamaria A et al., 2015The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Objective: To evaluate whether myo-inositol supplementation may reduce gestational diabetes mellitus (GDM) rate in overweight women.
Methods: In an open-label, randomized trial, myo-inositol (2 g plus...
Shaban MM et al., 2013The American Journal of the Medical Sciences
BACKGROUND: Nausea and vomiting during pregnancy are the most common conditions affecting pregnancy, occurring in about 80% of all pregnancies and always disappearing on the 16th to 18th weeks of gest...